Arcutis Biotherapeutics Inc. (ARQT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-12
09:55 am
Purchase
2026-03-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
STATE STREET CORP
STT
6,296,197
5.100%
4,771,152increase
(+312.85%)
Filing
History
2026-05-08
11:08 am
Sale
2026-03-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
PRUDENTIAL FINANCIAL INC
PRU
5,302,713
4.300%
-1,777,213decrease
(-25.10%)
Filing
History
2026-05-06
4:11 pm
Sale
2026-03-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Jennison Associates LLC4,980,770
4.000%
-1,777,236decrease
(-26.30%)
Filing
History
2026-03-26
11:13 am
Sale
2026-03-1313GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
VANGUARD GROUP INC0
0.000%
-4,896,513decrease
(Position Closed)
Filing
History
2026-02-13
4:08 pm
Sale
2025-12-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Rubric Capital Management LP8,271,577
6.750%
-2,695,095decrease
(-24.58%)
Filing
History
2026-02-13
3:08 pm
Sale
2025-12-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
PRUDENTIAL FINANCIAL INC
PRU
7,079,926
5.700%
-4,874,144decrease
(-40.77%)
Filing
History
2026-01-30
4:21 pm
Sale
2025-12-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Jennison Associates LLC6,758,006
5.500%
-5,496,113decrease
(-44.85%)
Filing
History
2025-10-06
5:46 pm
Purchase
2025-09-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Jennison Associates LLC12,254,119
10.200%
893,244increase
(+7.86%)
Filing
History
2025-08-20
5:19 pm
Purchase
2025-08-1813DARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Frazier Life Sciences VIII, L.P.8,943,712
7.500%
81,234increase
(+0.92%)
Filing
History
2025-08-14
08:04 am
Sale
2025-06-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Polar Capital Holdings Plc5,006,472
4.200%
-1,700,003decrease
(-25.35%)
Filing
History
2025-05-15
5:41 pm
Purchase
2025-03-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
PRUDENTIAL FINANCIAL INC
PRU
11,954,070
10.100%
2,069,933increase
(+20.94%)
Filing
History
2025-05-15
10:13 am
Purchase
2025-03-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Polar Capital Holdings Plc6,706,475
5.650%
408,787increase
(+6.49%)
Filing
History
2025-05-08
5:59 pm
Sale
2025-03-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Jennison Associates LLC11,360,875
9.600%
-767,658decrease
(-6.33%)
Filing
History
2024-11-14
7:50 pm
Sale
2024-09-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Point72 Asset Management, L.P.247,055
0.200%
-4,620,651decrease
(-94.92%)
Filing
History
2024-11-13
4:30 pm
Sale
2024-09-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Rubric Capital Management LP10,966,672
9.380%
-37,739,968decrease
(-77.48%)
Filing
History
2024-11-08
2:17 pm
Unchanged
2024-09-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
BlackRock, Inc.
BLK
9,029,624
7.700%
0
(Unchanged)
Filing
History
2024-11-06
4:00 pm
Sale
2024-09-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Morgan Stanley
MS
3,993,787
3.400%
-2,099,710decrease
(-34.46%)
Filing
History
2024-10-22
3:24 pm
Purchase
2024-09-3013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
BlackRock, Inc.
BLK
9,029,624
7.700%
3,113,078increase
(+52.62%)
Filing
History
2024-03-06
12:40 pm
Purchase
2024-03-0413DARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Frazier Life Sciences VIII, L.P.8,862,478
7.800%
21,052increase
(+0.24%)
Filing
History
2024-03-06
10:31 am
Purchase
2024-03-0613GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Jennison Associates LLC12,128,533
10.800%
3,062,451increase
(+33.78%)
Filing
History
Goto 0, 1, 2, Next